Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | Breakthrough in the treatment of Sudeck's dystropy (Chronic Regional Pain Syndrome, CRPS)The breakthrough has been discussed in an open access, international pain journal. Some years ago, it became clear that the cause of Sudeck is a neuro-inflammation. Physicians in the Netherlands developed a new treatment based on a natural, endogenous molecule and supplement, PeaPure (http://www.neuropathie.nu/ The mechanism of action of palmitoylethanolamide has been discovered in 1993 by the Nobel prize laureate professor Rita Levi-Montalcini. Since 1993 this compound has veen explored in many clinical trials, and proved to be effective and safe. Now it appears severe pains in Sudeck's dystrophy respond well to the treatment with palmitoylethanolamide. The severe edema (swelling) also vanished after treatment. PeaPure thus appears to be a new, effective and safe treatment for Sudeck. The article has appeared in the 'Journal of Pain Research' with the title:Treatment of chronic regional pain syndrome type 1 with palmitoylethanolamide and topical ketamine cream: modulation of nonneuronal cells. (http://www.dovepress.com/ Abstract: Chronic regional pain syndrome (CRPS) can be intractable to treat and patients sometimes suffer for many years. Therefore, new treatment strategies are needed to alleviate symptoms in CRPS patients. This case report describes a patient suffering from intractable CRPS type 1 for 13 years. Due to her swollen painful feet and left knee she is wheelchair-bound. The combination of palmitoylethanolamide and ketamine (http://www.neuropathie.nu/ Thus, palmitoylethanolamide and topical ketamine (http://www.neuropathie.nu/ Source:Keppel Hesselink JM, Kopsky DJ Treatment of chronic regional pain syndrome type 1 with palmitoylethanolamide and topical ketamine (http://www.dovepress.com/ End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|